On multivariate analysis, the presence of TET2 mutation was significantly and independently associated only with MPN-U diagnosis (P = 0.02 (OR: 2.81; 95% CI 1.11–7.06)). This evidence concerns the gene TET2 and myeloproliferative disorder.